Harrison Hayes Creates Angel Fund to Invest in Emerging Life Science Firms
Based on our broad contacts throughout the life sciences industry, we have made the decision to put together an Angel Fund that will invest up to $250,000 per transaction in emerging life science technology companies. We will invest in firms whose technologies and products are applicable across a wide range of segments including human healthcare therapeutics and diagnostics/devices; health/wellness; agricultural biotechnology; material science and industrial biotechnology (biomaterials/bioprocesses).
We employ a flexible investment approach to working with management and vendors and aim to align interests to the benefit of all. In our deals, management will have a significant financial stake in the company.
Harrison Hayes’ success is founded on building long-term relationships with entrepreneurs and portfolio companies. Over two decades of experience identifying, validating and backing emerging trends and technologies will provide our portfolio companies strategic advantages essential to success.
Please contact us at jcaldwell@harrisonhayes.com for an initial review. The further evaluation of the business proposals will be based on supporting technical materials such as an executive summary, business plan or investment memorandum.
Read More
Challenges of Innovation: Disruptive, Revolutionary and Evolutionary New Offerings
While many pharmaceutical and medical device firms are faced with the challenge of filling their new product pipelines, internal obstacles within the company may prevent a consistent and organized culture for innovation.
In a recent study conducted by Harrison Hayes, we spoke to forty (40) “innovation thought leaders” from pharmaceutical and device companies. These individuals are generally recognized within their respective companies as the leaders of innovation and change. As a result of this survey, we uncovered several key hurdles.
Read More
We Love Monocle!
If you have not checked out Monocle, a periodical self defined as a “Briefing on Global Affairs, Business, Culture and Design”, you owe it to yourself to pick up a copy. This is a stylish, innovative magazine which is an insightful read to any student of global trendspotting.
Perhaps the best way to define Monocle is a visually stimulating “Economist” with style and global swagger. Check out the Table of Contents for the Upcoming September issue.
Read More
MENA…The ‘Next’ Emerging Market
In the past several months we have witnessed a substantial increase in requests for customized research and market analysis studies for the MENA (Middle East/Northern Africa) region. It appears that many life science firms with presence in BRIC and Asia Pacific regions are looking for the next emerging market to broaden their global offerings. While challenges with regulatory, socio-economic, religious and cultural issues pose unique challenges, the promise of the continued double digit growth of the region’s $28 Billion pharmaceutical manufacturing industry shine a positive light on the potential.
Read More
Pages:
Featured Case Study
Strategic Positioning and New Markets
A leading disposables manufacturer sought to identify the potency of several of its disposable wound care brands to discern competitive…
Our Clients
Everything from developing new products, go-to-market strategies, and preparing annual marketing brand plans, I have no hesitation in recommending their work.
--Mary Minnick, Former Chief Marketing Officer
